Efficacy and Tolerability of a Probiotic Ointment
← catalyst calendarNCT07701447 · readout ≤ 833 d
Sponsored by BioGaia AB (industry) · BIOG-B.ST — their whole pipeline →. With Zurko Research.
Phase
Not applicable
Status
Not yet recruiting
Study type
Interventional
Design
Randomized · Single · Treatment
Enrollment
92estimated
Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →
Source: ClinicalTrials.gov, retrieved 2026-08-19
Dates
each axis at the precision it was filed, with the registry's own basis| Date | Filed | Basis | What it is |
|---|---|---|---|
| Start | Aug 2026 | estimated | When the study began enrolling |
| Primary completion | Nov 2028 | estimated | The date the last participant is measured for the primary outcome — the readout window |
| Study completion | Nov 2028 | estimated | The whole study's end, after follow-up |
| First posted | 2026-07-14 | actual | When this record first appeared on the registry |
| Results posted | — | When the sponsor posted results to the registry | |
| Record updated | 2026-07-15 | actual | The sponsor's own last edit to this record — every projection above is as current as this date |
What it studies
Condition
- Atopic Dermatitis
Interventions
- Other: Probiotic Ointment
- Other: Comparator product
Primary outcome
what the primary-completion date above is the date OFPrimary Endpoint
measured 28 days
Permalink · BIOG-B.ST's whole pipeline · Catalyst calendar · Every registered study · What changed